Correction of Glycogen Storage Disease Type II by Systemic Delivery of an AAV2/8 Vector Containing a Muscle-Specific Promoter

被引：0
|
作者：
Sun, Baodong [1 ]
Li, Ping [2 ]
Talmage, Brown [3 ]
Andrew, Bird [1 ]
Yan, Zhen [2 ]
Koeberl, Dwight D. [1 ]
机构：
[1] Duke Univ, Med Ctr, Div Med Genet, Durham, NC USA
[2] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[3] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.636
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
563
引用
收藏
页码：S217 / S217
页数：1
相关论文
共 40 条
  • [1] Correction of glycogen storage disease type II by intramuscular administration of an adeno-associated virus 6 (AAV2/6) vector containing a muscle-specific promoter
    Zhang, HY
    Sun, BD
    Franco, L
    Bird, A
    Schneider, A
    Koeberl, DD
    MOLECULAR THERAPY, 2004, 9 : S329 - S330
  • [2] Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter
    Sun, BD
    Zhang, HY
    Franco, LM
    Brown, T
    Bird, A
    Schneider, A
    Koeberl, DD
    MOLECULAR THERAPY, 2005, 11 (06) : 889 - 898
  • [3] Correction of glycogen storage disease type II (GSD II) with an adeno-associated virus 8 (AAV2/8) vector
    Sun, BD
    Zhang, HY
    Franco, L
    Schneider, A
    Bird, A
    Amalfitano, A
    Chen, YT
    Koeberl, DD
    MOLECULAR THERAPY, 2004, 9 : S265 - S266
  • [4] Sustained, high-level expression of human acid alpha-glucosidase and correction of glycogen storage disease type II (GSD II) with an adeno-associated virus 8 (AAV2/8) vector containing a liver-specific promoter
    Franco, LM
    Sun, BD
    Bird, A
    Zhang, HY
    Amalfitano, A
    Chen, YT
    Koeberl, DD
    MOLECULAR THERAPY, 2004, 9 : S129 - S129
  • [5] Correction of glycogenosis type 2 by muscle-specific lentiviral vector
    Emmanuel Richard
    Gaëlle Douillard-Guilloux
    Lionel Batista
    Catherine Caillaud
    In Vitro Cellular & Developmental Biology - Animal, 2008, 44
  • [6] Correction of glycogenosis type 2 by muscle-specific lentiviral vector
    Richard, Emmanuel
    Douillard-Guilloux, Gaealle
    Batista, Lionel
    Caillaud, Catherine
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2008, 44 (10) : 397 - 406
  • [7] Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector
    Sun, BD
    Chen, YT
    Bird, A
    Amalfitano, A
    Koeberl, DD
    MOLECULAR THERAPY, 2003, 7 (02) : 193 - 201
  • [8] Correction of Glycogen Storage Disease Type III with an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme
    Lim, Jeong-A
    Choi, Su Jin
    Gao, Fengqin
    Kishnani, Priya
    Sun, Baodong
    MOLECULAR THERAPY, 2019, 27 (04) : 17 - 17
  • [9] Skeletal muscle transduction with an AAV2/8 vector containing a sequence-optimized canine microdystrophin
    Koo, T.
    Shin, J. H.
    Okada, T.
    Athanasopoulos, T.
    Foster, H.
    Takeda, S.
    Dickson, G.
    HUMAN GENE THERAPY, 2011, 22 (10) : A63 - A63
  • [10] Correction of glycogen storage disease type II (GSD II) by intramuscular administration of an adeno-associated virus (AAV) vector pseudotyped as AAV6
    Sun, BD
    Chen, YT
    Bird, A
    Xu, F
    Amalfitano, A
    Koeberl, DD
    MOLECULAR THERAPY, 2003, 7 (05) : S391 - S391
1234